Cargando…
Mice deficient in endothelial α5 integrin are profoundly resistant to experimental ischemic stroke
Stroke is a disease in dire need of better therapies. We have previously shown that a fragment of the extracellular matrix proteoglycan, perlecan, has beneficial effects following cerebral ischemia via the α5β1 integrin receptor. We now report that endothelial cell selective α5 integrin deficient mi...
Autores principales: | Roberts, Jill, de Hoog, Leon, Bix, Gregory J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363730/ https://www.ncbi.nlm.nih.gov/pubmed/26661237 http://dx.doi.org/10.1177/0271678X15616979 |
Ejemplares similares
-
Intra‐arterial combination therapy for experimental acute ischemic stroke
por: Maniskas, Michael E., et al.
Publicado: (2021) -
The Inflammatory Response After Ischemic Stroke: Targeting β(2) and β(1) Integrins
por: Edwards, Danielle N., et al.
Publicado: (2019) -
Absence of endothelial α5β1 integrin triggers early onset of experimental autoimmune encephalomyelitis due to reduced vascular remodeling and compromised vascular integrity
por: Kant, Ravi, et al.
Publicado: (2019) -
Perlecan Domain V Induces VEGf Secretion in Brain Endothelial Cells through Integrin α(5)β(1) and ERK-Dependent Signaling Pathways
por: Clarke, Douglas N., et al.
Publicado: (2012) -
Successfully Climbing the “STAIRs”: Surmounting Failed Translation of Experimental Ischemic Stroke Treatments
por: Kahle, Michael P., et al.
Publicado: (2012)